All Business articles
View all stories with this category.
-
-
Business
Oxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
-
Business
Taking plastic out of performance paper coatings
SGMA’s silicate sol-gel is a sustainable alternative for packaging such as coffee cups
-
Business
Regulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
Business
Moderna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
Opinion
The ins and outs of vaccine trials
Derek Lowe lays out how the trials work, and why they get paused and restarted
-
Opinion
A promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
Business
Early indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
Business
Innovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
-
Sponsored
Informatics streamlines herbicide data management
MoA Technology leverages CDD Vault cheminformatics system to manage high-throughput herbicide screening data and external collaborations effectively. Here’s how
-
Business
Stepping towards diversity in industry
Companies are re-affirming their commitment to inclusivity, even as the US government obstructs education efforts
-
Opinion
Improving executive diversity is a priority
A few hiring decisions could make a big difference at leadership level
-
Business
Stretching liquid crystals to the limit with LC AuxeTec
The unintuitive properties of LC AuxeTec’s materials mean they thicken when stretched, and could be exploited in body armour and skyscraper windows
-
Business
EU commits to overhaul of chemicals legislation
The Chemicals Strategy for Sustainability promises the biggest reform since Reach
-
Business
Covid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
Opinion
The Nobel prize that got binned
Ferrocene is a classic example of a discovery that was dismissed as a failed experiment
-
Business
Arkema acquitted over hurricane fire emissions
US Judge rules there is insufficient evidence to bring criminal charges relating to peroxide fire caused by flooding in 2017
-
Opinion
Blood offering
Antibodies in various forms could bridge the Covid-19 treatment gap until a vaccine is available
-
Opinion
Jumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
Business
Covid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
